Welcome to LookChem.com Sign In|Join Free
  • or
2,3-dihydroxyquinolin-4(1H)-one, also known as 2,3-dihydroxy-1,4-quinolinedione, is a chemical compound characterized by a heterocyclic structure that includes a quinoline ring and two hydroxyl groups. 2,3-dihydroxyquinolin-4(1H)-one is frequently utilized as a chelating agent in coordination chemistry due to its ability to form stable complexes with metal ions.

2721-50-8

Post Buying Request

2721-50-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

2721-50-8 Usage

Uses

Used in Coordination Chemistry:
2,3-dihydroxyquinolin-4(1H)-one is used as a chelating agent for its capacity to bind with metal ions, forming stable complexes. This property makes it valuable in various applications within coordination chemistry, such as the development of new metal complexes with potential uses in catalysis, materials science, and medicinal chemistry.
Used in Biological Research:
In the field of biological research, 2,3-dihydroxyquinolin-4(1H)-one is studied for its potential antioxidant and antiproliferative properties. These characteristics suggest that it may have applications in the development of therapeutic agents for various diseases and conditions.
Used in Neurodegenerative Disease Treatment:
2,3-dihydroxyquinolin-4(1H)-one has been investigated for its potential role in the treatment of neurodegenerative diseases such as Alzheimer's and Parkinson's. Its biological activities, including antioxidant properties, may contribute to neuroprotective effects that could be beneficial in managing these conditions.
Used as a Corrosion Inhibitor:
2,3-dihydroxyquinolin-4(1H)-one has also been recognized for its potential use as a corrosion inhibitor. Its ability to chelate metal ions can help prevent the corrosion of metal surfaces, making it a candidate for use in industrial applications where corrosion control is necessary.
Used in Organic Synthesis:
Furthermore, 2,3-dihydroxyquinolin-4(1H)-one serves as a building block in the synthesis of complex organic molecules. Its structural features make it a versatile component in the creation of a wide range of organic compounds for use in pharmaceuticals, agrochemicals, and other specialty chemicals.

Check Digit Verification of cas no

The CAS Registry Mumber 2721-50-8 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 2,7,2 and 1 respectively; the second part has 2 digits, 5 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 2721-50:
(6*2)+(5*7)+(4*2)+(3*1)+(2*5)+(1*0)=68
68 % 10 = 8
So 2721-50-8 is a valid CAS Registry Number.

2721-50-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 3,4-dihydroxy-1H-quinolin-2-one

1.2 Other means of identification

Product number -
Other names 2,4-Quinolinetriol

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:2721-50-8 SDS

2721-50-8Relevant academic research and scientific papers

4-Hydroxy-2-quinolones. 37. Simple synthesis of 1-R-2-oxo-3,4-dihydroxyquinolines

Ukrainets,Taran,Sidorenko,Gorokhova

, p. 1334 - 1336 (2007/10/03)

3-Amino-1-R-2-oxo-4-hydroxyquinolines easily undergo acid hydrolysis with formation of the corresponding 1-R-2-oxo-3,4-dihydroxyquinolines. 1998 Plenum Publishing Corporation.

Glycine receptor antagonist pharmacophore

-

, (2008/06/13)

Methods of treating or preventing neuronal loss associated with stroke, ischemia, CNS trauma, hypoglycemia and surgery, as well as treating neurodegenerative diseases including Alzheimer''s disease, amyotrophic lateral sclerosis, Huntington''s disease and Down''s syndrome, treating or preventing the adverse consequences of the hyperactivity of the excitatory amino acids, as well as treating anxiety, chronic pain, convulsions and inducing anesthesia are disclosed by administering to an animal in need of such treatment a compound which has high binding to the glycine receptor.

Ylides of Heterocycles, VIII. Reactions of Iodonium-Ylides with Acids

Pongratz, Erik,Kappe, Thomas

, p. 231 - 242 (2007/10/02)

The reaction of various organic and inorganic acids (HX) with iodonium ylides 2 leads to nucleophilic substitution of the iodobenzene substituent by the anion X(-) to yield the heterocycles 5.Some of them are hydrolyzed to the hydroxy compounds 3 or reduced to the starting compounds 1 under the reaction conditions.Reaction of the iodonium ylide 2b with monomethyl sulfate gives the salt 9, which with bases undergoes nucleophilic substitution to compounds 8 and 10-12, respectively, or is converted to 2b again. - Keywords: 3-Acetoxy-4-hydroxy-2-quinolones; 2-Oxoquinoline-4-olates; 3-Substituted 4-hydroxy-2-quinolones

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 2721-50-8